Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Altura Medical Inc.

This article was originally published in Start Up

Executive Summary

Altura Medical is developing a percutaneous, low-profile endovascular stent-graft for the treatment of AAAs designed to eliminate some of the major issues associated with conventional endograft procedure safety, efficacy and complexity. The company's plan is to provide a flexible, off-the-shelf, ultra-low profile device with an industry-first 12 French inside diameter. The Altura system may be placed routinely in the cath lab as an outpatient procedure, and in more difficult AAA anatomies that are usually referred for open surgery, including those patients with short necks or smaller, tortuous iliac arteries.

Related Content

Expanding The EVAR Toolbox: A Glimpse Into The Future
Abingworth's Bet On Lombard: Best Of Both Worlds For VCs
EVAR Market: Challenges, Innovation and Growth
EVAR Market: Challenges, Innovation and Growth
EVAR Market: Challenges, Innovation and Growth
Endoluminal Sciences Pty Ltd.
Advancing The Technological Frontier In AAA Repair
Start-Up Previews (04/2011)
Aptus Endosystems Inc.


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts